Healthcare ECONOMIST

MARCH 17, 2023

Through what mechanisms are patients and physicians made aware of new pharmaceuticals and decide to prescribe them. It is well known that physician peer networks often help share information about new pharmaceuticals including clinical information as well as the providers own experience using the new treatment.

Pharmaceuticals 80

Pharmaceuticals Ambulatory Care Medical Services 80

Sheppard Health Law

OCTOBER 25, 2023

and the City of Chicago, Illinois, in further regulating the activities of pharmaceutical representatives. The Act builds on Governor Lamont’s policy initiatives , which aim to improve the delivery of care and reduce healthcare costs for Connecticut residents and includes the initiative to regulate pharmaceutical marketing practices.

Pharmaceuticals 52

Pharmaceuticals Regulations Healthcare 52

NASHP

SEPTEMBER 22, 2021

2021 State Legislative Action to Lower Pharmaceutical Costs Updated September 22, 2021. Find the status of state legislation to address prescription drug costs below. Use the category button to search by type of legislation and roll over a state to view its pending drug legislation.

Pharmaceuticals 102

Pharmaceuticals 102

Fierce Healthcare

SEPTEMBER 3, 2024

There's no shortage of attention on rising pharmaceutical costs, but policymakers need to have the full picture of trends in this space to work off of, according to a new study.

Accountability 315

Accountability Pharmaceuticals 315

HIT Consultant

DECEMBER 11, 2023

What You Should Know: – Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV , a pharmaceutical company, to further advance AI-powered solutions in the medical field. Cosmo Pharmaceuticals remains the exclusive manufacturer of the platform.

Pharmaceuticals 52

Pharmaceuticals Integration Healthcare Life Sciences 52

Healthcare ECONOMIST

SEPTEMBER 15, 2021

Is it new surgical techniques, better diagnostics, improved medical devices, or new pharmaceuticals? Based on physicians responses, across all 8 diseases , pharmaceuticals had the largest impact on health. Across all 8 diseases 56% of the relative value came from pharmaceuticals. Clearly public health initiatives (e.g.,

Pharmaceuticals 79

Pharmaceuticals Medical Technology Accountability 79

HIT Consultant

OCTOBER 25, 2022

The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.

Pharmaceuticals 98

Pharmaceuticals Regulations Doctors Health Technology 98

NASHP

MAY 30, 2023

ET Register The post State-Only Call: Federal Pharmaceutical Drug Legislation appeared first on NASHP. Speakers Yvette Fontenot , Health Policy Expert, Avenue Solutions Andrew McKechnie , Government Relations Consultant, Tiber Creek Group Monday, June 5, 4–4:30 p.m.

Pharmaceuticals 52

Pharmaceuticals Hospitals 52

NASHP

JANUARY 1, 2023

The post 2023 State Legislative Action to Lower Pharmaceutical Costs appeared first on NASHP. Email Allison McDowell. Download archived trackers for previous years : 2022 , 2021 , 2020 , 2019 , 2018 , 2017 , and 2015-2016.

Pharmaceuticals 59

Pharmaceuticals 59

Healthcare ECONOMIST

AUGUST 8, 2023

That is the subtitle of an NBER working paper by Charles Gray, Abby E. Alpert & Neeraj Sood. The author examine recent mergers between pharmacy benefit managers (PBMs) and health insurers. On the one hand, integration may beneficial to consumers. better accounting for medical costs offsets).

Pharmaceuticals 89

Pharmaceuticals Integration Accountability Medicare 89

Health Care Dive

AUGUST 21, 2024

The growing burden of pharmaceuticals is expected to be the primary driver of higher healthcare spending in 2025, mostly due to expensive GLP-1 drugs in demand for weight loss, according to the Business Group on Health.

Pharmaceuticals 312

Pharmaceuticals Healthcare 312

Bill Of Health

JULY 20, 2022

Section 340B of the Public Health Service Act requires that pharmaceutical manufacturers give discounts on specified outpatient drugs to certain covered entities who typically serve low-income or otherwise underserved patients, including hospitals and clinics. By Amy Cook, JD, Jonathan Larsen, JD, MPP, and Sabrina Ruchelli, JD.

Pharmaceuticals 59

Pharmaceuticals Hospitals Public Health services Accountability 59

Sheppard Health Law

NOVEMBER 21, 2022

Pharmaceutical manufacturers are challenging the breadth of the Federal Anti-Kickback Statute (“AKS”) in federal court, arguing that the government is harming the very vulnerable patients it aims to serve by prohibiting cost-sharing subsidies for life-saving oncology drugs.

Pharmaceuticals 52

Pharmaceuticals Medicare Integration Doctors 52

Health Care Dive

JUNE 29, 2023

Providers are expected to seek rate increases from payers as they struggle with labor costs, while health plans will face pressure from increased pharmaceutical expenses.

Pharmaceuticals 334

Pharmaceuticals Healthcare 334

Fierce Healthcare

JUNE 24, 2024

Atropos Health's Evidence Network has grown to include the data resources of pharmaceutical-focused Forian and international patient data resources from Syndesis. The two new additions, Forian and Syndesis, will bring more pharmaceutical and international patient data to users of the network.

Pharmaceuticals 170

Pharmaceuticals Healthcare 170

Healthcare ECONOMIST

OCTOBER 10, 2024

That is the question considered by Wouters and Kuha (2024) in a recent Health Affairs article. The authors use IQVIA data between 1982 and 2024 on the timing of drug launches and estimate median delay times using a Kaplan Meier estimates. They find that: From the first launch globally, the median time to availability was 2.7

Pharmaceuticals 63

Pharmaceuticals 63

Health Care Dive

OCTOBER 14, 2024

Several groups have been granted additional time to comply with the more than 10-year-old legislation, which requires complete end-to-end supply chain visibility for pharmaceutical products.

Pharmaceuticals 147

Pharmaceuticals 147

Fierce Healthcare

DECEMBER 14, 2023

The Biden administration is cracking down on pharmaceutical companies as part of its price-fighting measures under the Inflation Reduction Act. | The Biden Administration announced Thursday a list of 48 Part B drugs with prices that rose faster than the rate of inflation in the final quarter of 2023. Here's what they plan to do now.

Pharmaceuticals 304

Pharmaceuticals Medicare 304

Fierce Healthcare

SEPTEMBER 13, 2023

Pharmaceutical companies are waging war against federal agencies over one of the Inflation Reduction Act’s major provisions allowing Medicare to negotiate 10 drugs to reduce out-of-pocket costs for | Legal experts question whether the Inflation Reduction Act is within its rights to enforce its drug pricing negotiation provision.

Pharmaceuticals 315

Pharmaceuticals Medicare 315

Fierce Healthcare

OCTOBER 19, 2023

The Mayo Clinic and LifePoint Health believe that collusion within pharmaceutical industry forced their organizations to overpay for the multiple myeloma drug Revlimid, and are petitioning the cour | The health systems said agreements between Revlimid's owners, Celgene and Bristol-Myers Squibb, and other drugmakers that delayed full production (..)

Pharmaceuticals 315

Pharmaceuticals 315

Fierce Healthcare

AUGUST 8, 2024

Pharmaceutical giant Roche bought health tech startup Flatiron Health for $1.9 billion in 2018 to expand its reach into real-world evidence and accelerate its development of cancer medicines. Swiss pharma giant Roche is considering divesting Flatiron Health six years after it bought the startup for $1.9

Pharmaceuticals 187

Pharmaceuticals 187

Healthcare ECONOMIST

JULY 11, 2024

This is the title of a new paper I have out today at JMCP with co-authors Shanshan Wang, Jaehong Kim, Slaven Sikirica, and Alexander Sandhu with the subtitle “ An economic model measuring the impact of sotagliflozin among patients with heart failure and diabetes “ An abstract is below: BACKGROUND : Heart failure (HF) is among the leading (..)

Pharmaceuticals 70

Pharmaceuticals Accountable Care Accountability Hospitals 70

Fierce Healthcare

AUGUST 29, 2024

Higher volumes, rates and pharmaceutical expenses have so far spelled a tough 2024 for UPMC's insurance division. Pittsburgh-based UPMC’s operations are $313 million in the red (-2.2% operating margin) halfway through 2024, the integrated nonprofit system reported in a Thursday filing.

Pharmaceuticals 159

Pharmaceuticals Integration 159

Health Care Dive

MARCH 16, 2023

The guidance fills in details for one of the central pharmaceutical provisions of the Inflation Reduction Act, signaling how the agency will use its new authority.

Pharmaceuticals 290

Pharmaceuticals 290

Fierce Healthcare

AUGUST 31, 2023

The American Telemedicine Association, the College of Healthcare Information Management Executives (CHIME) and Otsuka America Pharmaceutical are among the groups in support of the Centers for Medic | Organizations signed a letter pledging support for a CMS-backed transitional coverage for emergency technologies pathway, which they say could improve (..)

Telemedicine 276

Telemedicine Pharmaceuticals Prevention Hospitals 276

Health Care Dive

JANUARY 19, 2023

Previously, Adam Kautzner led pharmaceutical and retail network contracting and drug sourcing as vice president of supply chain for the PBM and Accredo Pharmacy.

Pharmaceuticals 298

Pharmaceuticals 298

Fierce Healthcare

MARCH 14, 2024

Pharmaceutical costs, non-claims payments and outpatient care fueled “unchecked” healthcare spending in Massachusetts that's increasingly being felt by its residents, according to new findings from | The Bay State's healthcare cost growth benchmark program is calling for policy action after a report showed per-person health spending well (..)

Regulations 216

Regulations Pharmaceuticals Healthcare 216

Fierce Healthcare

AUGUST 21, 2023

In a federal lawsuit, AARP is supporting Medicare’s new ability to negotiate drug prices with pharmaceutical companies, ahead of CMS naming the first 10 prescription drugs next month. The nation’s leading lobbying group for older Americans is supporting the U.S. |

Medicare 246

Medicare Pharmaceuticals 246

HIT Consultant

NOVEMBER 21, 2024

. – Converge Bio’s platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time. Designing mRNA vaccines optimized for robust immune responses.

Pharmaceuticals 97

Pharmaceuticals Biotechnology Life Sciences 97

Fierce Healthcare

MARCH 13, 2024

The three-judge panel's ruling, which could be appealed, could spur action in other states.

Pharmaceuticals 284

Pharmaceuticals 284

Fierce Healthcare

AUGUST 8, 2023

Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it faces economic pressures and slowing sales am | Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it (..)

Pharmaceuticals 246

Pharmaceuticals 246

Healthcare It News

JANUARY 31, 2024

They can quickly be integrated into manufacturing lines, which means embedded RFID technologies are no longer hindering pharmaceutical manufacturing. “It ensures all parties can easily interact with pharmaceutical products at any point in the supply chain, resulting in a more cohesive and efficient ecosystem.”

Healthcare 300

Healthcare Pharmaceuticals Patient Safety Life Sciences 300

Health Care Dive

FEBRUARY 8, 2023

The health insurer’s national formulary considers Amylyx Pharmaceuticals’ Relyvrio to be "experimental, investigational or unproven for any use,” and now does not recommend covering it.

Pharmaceuticals 246

Pharmaceuticals 246

Health Care Dive

APRIL 29, 2022

But a tricky dosing regimen, as well as safety concerns, could challenge the pharmaceutical giant's lofty forecast. Bristol Myers paid $13 billion to acquire the drug's maker, MyoKardia, and expects it to become a blockbuster.

Pharmaceuticals 298

Pharmaceuticals 298

HIT Consultant

NOVEMBER 18, 2024

What You Should Know: – NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design. The BioNeMo Blueprint for virtual screening, for example, streamlines the process of designing small molecules.

Pharmaceuticals 93

Pharmaceuticals Integration Life Sciences Healthcare 93

Health Care Dive

AUGUST 26, 2022

The biotech claims its rivals’ vaccine Comirnaty, one of the world’s top-selling pharmaceutical products, infringes on two patents covering its messenger RNA technology.

Pharmaceuticals 246

Pharmaceuticals 246

Fierce Healthcare

AUGUST 23, 2023

The cost of pharmaceuticals is a key topic for policymakers on the Hill, and it should come as no surprise that it's also a major concern for employers across the country. |

Pharmaceuticals 130

Pharmaceuticals 130